author-photo

George Vlachogiannis

Institute of Cancer Research

10

Papers

82

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Prospective analysis of microRNA 31-3p (miR31-3p) as a predictive biomarker of response to anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies (mABs) in patients with metastatic colorectal cancer (mCRC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 2646: Proteomic approaches to study cetuximab resistance inRAS/BRAFwild type colorectal cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-094: Suppression of inflammatory gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

2018 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (37)
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study

2018 Gut
Show All
- Source
- Cite
- Save
Citations (42)
Metastatic colorectal cancer (mCRC) patient derived organoids (PDOs) as a preclinical tool to understand mechanisms of resistance to anti-angiogenic drugs

2017 Ejso
Show All
- Source
- Cite
- Save
Citations (0)
Magnetic resonance Imaging (MRI), liquid biopsies, and patient derived organoids (PDOs) as biomarkers of response to regorafenib (REG) in treatment-refractory metastatic colorectal cancer (mCRC) patients (pts).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)